Skip to main content

Published locations for FDA investigating risk of gadolinium contrast agent brain deposits

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA investigating risk of gadolinium contrast agent brain deposits

User login

  • Reset your password
  • /content/fda-investigating-risk-gadolinium-contrast-agent-brain-deposits
  • /emed-journal/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain-deposits
  • /familypracticenews/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /ehospitalistnews/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /internalmedicinenews/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /oncologypractice/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /hematology-oncology/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /internalmedicine/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /neurology/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain-deposits
  • /familymedicine/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /emergencymedicine/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain
  • /clinicalneurologynews/article/101712/imaging/fda-investigating-risk-gadolinium-contrast-agent-brain